Neurocrine Bioscience buy Needham & Company LLC
Start price
15.04.25
/
50%
€86.30
Target price
15.04.26
€121.87
Performance (%)
37.31%
Price
16:25
€118.50
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL for Neurocrine Bioscience has seen massive gains of 37.31%. This prediction currently runs until 15.04.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -3.662% | -3.662% |
| iShares Core DAX® | 0.696% | -0.706% |
| iShares Nasdaq 100 | 0.033% | 4.900% |
| iShares Nikkei 225® | -0.420% | 6.468% |
| iShares S&P 500 | 0.153% | 2.911% |
Comments by Needham___Company_LL for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $138.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.40
22.09.25
22.09.25
€144.89
22.09.26
22.09.26
-4.94%
16:25
16:25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.35
06.05.25
06.05.25
€123.07
06.05.26
06.05.26
5.25%
16:25
16:25